19 Apr 2024
Publication of Stage 1 and Stage 2 PBS Process Improvements metrics report for 2022-23
Publication of Stage 1 and Stage 2 PBS Process Improvements metrics report for 2022-23
15 Apr 2024
Updates to the HTA Policy and Methods Review Reference Committee – 15 April 2024
Updates to the HTA Policy and Methods Review Reference Committee – 15 April 2024
05 Apr 2024
PBAC Public Summary Documents – December 2023 meeting
PBAC Public Summary Documents – December 2023 meeting
03 Apr 2024
National Health (Pharmaceutical Benefits) Regulations 2017 amendments
National Health (Pharmaceutical Benefits) Regulations 2017 amendments
03 Apr 2024
Agenda for the July 2024 PBAC meeting – 3 April 2024
Agenda for the July 2024 PBAC meeting – 3 April 2024
02 Apr 2024
Public Consultation: Draft 2024-25 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP
Consultation on the draft 2024-25 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical Benefits Scheme (PBS) and designated vaccines on the National Immunisation Program (NIP) is now open.
01 Apr 2024
1 April 2024 designated brand list – minimum stockholding requirements
1 April 2024 designated brand list – minimum stockholding requirements
28 Mar 2024
Stocktake of PBS medicines available for endometriosis and related conditions Report
Stocktake of PBS medicines available for endometriosis and related conditions Report
26 Mar 2024
Updates to the HTA Policy and Methods Review Reference Committee – 26 March 2024
Updates to the HTA Policy and Methods Review Reference Committee – 26 March 2024
